Pier-Luigi Lollini
Pier-Luigi Lollini
Professor of Molecular Oncology, University of Bologna, Italy
Verified email at unibo.it - Homepage
Cited by
Cited by
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
E Di Carlo, G Forni, PL Lollini, MP Colombo, A Modesti, P Musiani
Blood, The Journal of the American Society of Hematology 97 (2), 339-345, 2001
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice
S Rovero, A Amici, E Di Carlo, R Bei, P Nanni, E Quaglino, P Porcedda, ...
The Journal of Immunology 165 (9), 5133-5142, 2000
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ...
The Journal of experimental medicine 188 (3), 589-596, 1998
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
R Ferracini, MFR Di, K Scotlandi, N Baldini, M Olivero, P Lollini, ...
Oncogene 10 (4), 739-749, 1995
Vaccines for tumour prevention
PL Lollini, F Cavallo, P Nanni, G Forni
Nature Reviews Cancer 6 (3), 204-216, 2006
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi, MC Manara, G Nicoletti, PL Lollini, S Lukas, S Benini, S Croci, ...
Cancer research 65 (9), 3868-3876, 2005
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice
P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ...
The Journal of experimental medicine 194 (9), 1195-1206, 2001
2011: the immune hallmarks of cancer
F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini
Cancer Immunology, Immunotherapy 60 (3), 319-326, 2011
Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target
K Scotlandi, S Benini, M Sarti, M Serra, PL Lollini, D Maurici, P Picci, ...
Cancer research 56 (20), 4570-4574, 1996
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice
K Scotlandi, S Benini, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, M Serra, ...
Cancer research 58 (18), 4127-4131, 1998
TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma
P Nanni, C De Giovanni, PL Lollini, G Nicoletti, G Prodi
Clinical & experimental metastasis 1 (4), 373-380, 1983
Cytokines, tumour-cell death and immunogenicity: a question of choice
P Musiani, A Modesti, M Giovarelli, F Cavallo, G Forni, PL Lollini, ...
Immunology today 18 (1), 32-36, 1997
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumorá…
A Allione, M Consalvo, P Nanni, PL Lollini, F Cavallo, M Giovarelli, ...
Cancer research 54 (23), 6022-6026, 1994
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice
E Quaglino, M Iezzi, C Mastini, A Amici, F Pericle, E Di Carlo, SM Pupa, ...
Cancer Research 64 (8), 2858-2864, 2004
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells
S Benini, MC Manara, N Baldini, V Cerisano, M Serra, M Mercuri, ...
Clinical Cancer Research 7 (6), 1790-1797, 2001
NVP-BEZ235 as a new therapeutic option for sarcomas
MC Manara, G Nicoletti, D Zambelli, S Ventura, C Guerzoni, L Landuzzi, ...
Clinical Cancer Research 16 (2), 530-540, 2010
Preclinical in vivo study of new insulin-like growth factor-I receptor–specific inhibitor in Ewing's sarcoma
MC Manara, L Landuzzi, P Nanni, G Nicoletti, D Zambelli, PL Lollini, ...
Clinical Cancer Research 13 (4), 1322-1330, 2007
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas
C Curcio, E Di Carlo, R Clynes, MJ Smyth, K Boggio, E Quaglino, ...
The Journal of clinical investigation 111 (8), 1161-1170, 2003
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
C Garofalo, MC Manara, G Nicoletti, MT Marino, PL Lollini, A Astolfi, ...
Oncogene 30 (24), 2730-2740, 2011
Immunoprevention of cancer: is the time ripe?
G Forni, PL Lollini, P Musiani, MP Colombo
Cancer Research 60 (10), 2571-2575, 2000
The system can't perform the operation now. Try again later.
Articles 1–20